202783528	202783528	CD	B-NP	O
|	|	NN	I-NP	O
HMH	HMH	NN	I-NP	O
|	|	NN	I-NP	O
78284036	78284036	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5991209	5991209	CD	B-NP	O
|	|	CC	I-NP	O
10/28/2005	10/28/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Epididymitis	Epididymitis	NNP	I-NP	O
,	,	,	O	O
UTI	UTI	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/17/2005	1/17/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2005	7/15/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HILLERMAN	HILLERMAN	NN	B-NP	O
,	,	,	O	O
JAYSON	JAYSON	NN	B-NP	O
511-27-80-0	511-27-80-0	CD	I-NP	O
I	I	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/5/05	1/5/05	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CRESPO	CRESPO	NNP	B-NP	O
,	,	,	O	O
EMMITT	EMMITT	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
300	300	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
MICHONSKI	MICHONSKI	NN	B-NP	O
,	,	,	O	O
IKE	IKE	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

SERIOUS	SERIOUS	JJ	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ATENOLOL	ATENOLOL	NN	B-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
DOMENICE	DOMENICE	NN	B-NP	O
,	,	,	O	O
JERROD	JERROD	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LASIX	LASIX	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
30353529	30353529	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Sulfa	Sulfa	NNP	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Rash	Rash	NN	B-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
LISINOPRIL	LISINOPRIL	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
TANT	TANT	NN	B-NP	B-protein
,	,	,	O	O
ALEXANDER	ALEXANDER	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NN	B-NP	B-protein
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54827963	54827963	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
HYTRIN	HYTRIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TERAZOSIN	TERAZOSIN	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
LAURENCE	LAURENCE	NN	B-NP	O
,	,	,	O	O
DESMOND	DESMOND	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
36950907	36950907	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/5/05	1/5/05	CD	B-NP	O
by	by	IN	B-PP	O
SCHNEIDERMAN	SCHNEIDERMAN	NNP	B-NP	O
,	,	,	O	O
NORMAND	NORMAND	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
54957260	54957260	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ALLOPURINOL	ALLOPURINOL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
med	me	VBD	B-VP	O
ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
3	3	CD	B-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
44	44	CD	B-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NASONEX	NASONEX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MOMETASONE	MOMETASONE	NNP	I-NP	O
FUROATE	FUROATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
OINTMENT	OINTMENT	NNP	I-NP	O
TP	TP	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
WELLBUTRIN	WELLBUTRIN	NN	I-NP	O
SR	SR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
BUPROPION	BUPROPION	NN	I-NP	O
HCL	HCL	NN	I-NP	O
SUSTAINED	SUSTAINED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
X	X	SYM	B-VP	O
14	14	CD	B-NP	O
doses	dose	NNS	I-NP	O
Food/Drug	Food/Drug	NNP	B-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/18/05	10/18/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
11/18	11/18	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
BHC	BHC	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
Furrow	Furrow	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
Sulfa	Sulfa	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Scrotal	Scrotal	NNP	B-NP	O
Cellulitis	Cellulitis	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Epididymitis	Epididymitis	NNP	I-NP	O
,	,	,	O	O
UTI	UTI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diverticulitis	diverticulitis	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
urethral	urethral	JJ	I-NP	O
strictures	stricture	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Depression	Depression	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
depression	depression	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DVT	DVT	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CT	CT	NNP	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
Scrotal	Scrotal	NNP	B-NP	O
US	US	NNP	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
ECHO	ECHO	NN	I-NP	O
,	,	,	O	O
bladder	bladder	NN	B-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
labs	lab	NNS	B-NP	O
,	,	,	O	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Scrotal	Scrotal	JJ	B-NP	O
edema	edema	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
y	y	NN	I-NP	O
'	'	POS	B-NP	O
o	o	NN	I-NP	O
man	man	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
a	a	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
UTIs	UTI	NNS	I-NP	O
,	,	,	O	O
urethral	urethral	JJ	B-NP	O
strictures	stricture	NNS	I-NP	O
likely	likely	RB	B-ADJP	O
2ndary	2ndary	JJ	I-ADJP	O
to	to	TO	B-PP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
gonorrhea	gonorrhea	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
urethral	urethral	JJ	B-NP	O
dilatation	dilatation	NN	I-NP	O
8/10	8/10	CD	I-NP	O
and	and	CC	O	O
subseqeunt	subseqeunt	NN	B-NP	O
self-cath/dilatation	self-cath/dilatation	NN	I-NP	O
as	as	RB	B-ADVP	O
recently	recently	RB	I-ADVP	O
as	as	IN	B-PP	O
10/6	10/6	CD	B-NP	O
who	who	WP	B-NP	O
p/w	p/w	VBP	B-VP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
frequency	frequency	NN	I-NP	O
,	,	,	O	O
urgency	urgency	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
incontinence	incontinence	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
scrotal	scrotal	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Saw	Saw	NN	B-NP	O
PCP	PCP	NN	I-NP	O
8/22	8/22	CD	I-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
scrotal	scrotal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
nitrofurantoin	nitrofurantoin	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
resolution	resolution	NN	I-NP	O
in	in	IN	B-PP	O
UTI	UTI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
but	but	CC	O	O
persistentfevers	persistentfever	NNS	B-NP	O
f/b	f/b	VBP	B-VP	O
development	development	NN	B-NP	O
of	of	IN	B-PP	O
scrotal	scrotal	JJ	B-NP	O
swelling	swell	VBG	I-NP	O
and	and	CC	I-VP	O
sqeezing	sqeeze	VBG	I-VP	O
scrotal	scrotal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
n/v/d	n/v/d	NN	I-NP	O
/	/	SYM	B-VP	O
recent	recent	JJ	B-NP	O
travel/recent	travel/recent	JJ	I-NP	O
STDs	STD	NNS	I-NP	O
.	.	.	O	O

Not	Not	RB	O	O
sexually	sexually	RB	B-ADJP	O
active	active	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
prostatitis	prostatitis	NN	B-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
Levo	Levo	NNP	B-NP	O
and	and	CC	I-NP	O
Cefotax	Cefotax	NNP	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
neg	neg	NN	B-NP	O
CT	CT	NN	I-NP	O
abd	abd	NN	I-NP	O
pelvis	pelvis	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
=	=	SYM	B-VP	O
101.0	101.0	CD	B-NP	O
HR	HR	NN	I-NP	O
=	=	SYM	B-VP	O
95	95	CD	B-NP	O
R	R	NN	I-NP	O
=	=	SYM	B-VP	O
20	20	CD	B-NP	O
BP	BP	NN	I-NP	O
=	=	SYM	B-VP	O
102/64	102/64	CD	B-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Obese	Obese	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
MMM	MMM	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	O
7cm	7cm	NN	I-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
Nl	Nl	NN	I-NP	I-protein
s1	s1	NN	I-NP	I-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
Holosystolic	Holosystolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
greatest	great	JJS	B-ADVP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
ND/NT	ND/NT	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
inguinal	inguinal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Scrotum	Scrotum	NNP	B-NP	O
erythematous	erythematous	NNP	I-NP	O
,	,	,	O	O
warm	warm	JJ	B-NP	O
,	,	,	I-NP	O
swollen	swollen	JJ	I-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

Could	Could	MD	B-VP	O
not	not	RB	I-VP	O
palpate	palpate	VB	I-VP	O
epidydymis	epidydymis	NN	B-NP	O
.	.	.	O	O

penile	penile	JJ	B-NP	O
retraction	retraction	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DPP	DPP	NN	I-NP	B-protein
,	,	,	O	O
venous	venous	JJ	B-NP	O
statis	statis	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

CTabd/Pelvis	CTabd/Pelvis	NN	B-NP	O
-	-	HYPH	B-PP	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
horshoe	horshoe	NN	B-NP	O
kidney	kidney	NN	I-NP	O
,	,	,	O	O
steatic	steatic	JJ	B-NP	O
hepatosis	hepatosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
scrotal	scrotal	JJ	B-NP	O
thickening	thickening	NN	I-NP	O
.	.	.	O	O

Scrotal	Scrotal	JJ	B-NP	O
US	US	NNP	I-NP	O
-	-	HYPH	I-NP	O
No	No	NNP	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
torsion	torsion	NN	B-NP	O
.	.	.	O	O

Pos	Po	NNS	B-NP	B-protein
for	for	IN	B-PP	O
epididymitis	epididymitis	NN	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
55	55	CD	B-NP	O
y	y	NN	I-NP	O
'	'	POS	B-NP	O
o	o	NN	I-NP	O
man	man	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
BPH	BPH	NN	B-NP	B-protein
.	.	.	O	O

urethral	urethral	JJ	B-NP	O
strictures	stricture	NNS	I-NP	O
,	,	,	O	O
recuurent	recuurent	JJ	B-NP	O
UTIS	UTIS	NN	I-NP	O
,	,	,	O	O
here	here	RB	B-ADVP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
UTI	UTI	NN	I-NP	O
and	and	CC	O	O
likely	likely	JJ	B-NP	O
scrotal	scrotal	JJ	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
v.	v.	NN	I-NP	O
hydrocele	hydrocele	NN	I-NP	O
v.	v.	NN	I-NP	O
epidydimitis	epidydimitis	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
GU	GU	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
UTI	UTI	NN	I-NP	B-cell_line
w	w	NN	I-NP	I-cell_line
/	/	SYM	B-VP	I-cell_line
urine	urine	NN	B-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
performed	perform	VBN	B-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
E.coli	E.coli	NNP	B-NP	O
per	per	IN	B-PP	O
FUMC	FUMC	NNP	B-NP	O
record	record	NN	B-NP	O
:	:	:	O	O
Treating	Treat	VBG	B-VP	O
with	with	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
.	.	.	O	O

Epididymitis	Epididymitis	NN	B-NP	O
-	-	HYPH	O	O
covering	cover	VBG	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
.	.	.	O	O

Continuing	Continue	VBG	B-VP	O
terazosin	terazosin	NN	B-NP	O
for	for	IN	B-PP	O
BPH	BPH	NN	B-NP	O
.	.	.	O	O

Post-void	Post-void	JJ	B-NP	O
bladder	bladder	NN	I-NP	O
scan	scan	NN	I-NP	O
ontained	ontaine	VBD	B-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
residuals	residual	NNS	B-NP	O
.	.	.	O	O

Encouraging	Encourage	VBG	B-VP	O
daily	daily	JJ	B-NP	O
staright	staright	NN	I-NP	O
cath	cath	NN	I-NP	O
3-4cm	3-4cm	NN	I-NP	O
into	into	IN	B-PP	O
urethral	urethral	JJ	B-NP	O
meatus	meatus	NN	I-NP	O
to	to	TO	B-VP	O
prevent	prevent	VB	I-VP	O
re-stenosis	re-stenosis	NN	B-NP	O
.	.	.	O	O

Teching	Teching	NN	B-NP	O
performed	perform	VBN	B-VP	O
for	for	IN	B-PP	O
patient	patient	NN	B-NP	O
and	and	CC	I-NP	O
partners	partner	NNS	I-NP	O
on	on	IN	B-PP	O
procedure	procedure	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	B-NP	O
New	New	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
performed	perform	VBN	B-VP	O
with	with	IN	B-PP	O
results	result	NNS	B-NP	O
pending	pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
ACE	ACE	NN	I-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
isosorbide	isosorbide	NN	B-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
reg	reg	NN	I-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Pulm	Pulm	NN	I-NP	B-protein
-	-	HYPH	O	O
CPAP	CPAP	NN	B-NP	B-protein
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
+	+	SYM	B-NP	O
TEDS	TEDS	NN	I-NP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
,	,	,	O	O
PPI	PPI	NN	B-NP	B-protein
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
-	-	HYPH	B-NP	O
1	1	CD	I-NP	O
pill	pill	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
If	If	IN	B-SBAR	O
scrotal	scrotal	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
redness	redness	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
pain	pain	NN	B-NP	O
get	get	VBP	B-VP	O
worse	worse	JJR	B-ADJP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
persistent	persistent	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
please	please	VB	B-VP	O
phone	phone	NN	B-NP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NN	I-NP	O
room	room	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Please	Please	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
ECHO	ECHO	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
straight	straight	RB	B-VP	O
catheterize	catheterize	VBP	I-VP	O
yourself	yourself	PRP	B-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
the	the	DT	B-NP	O
urethral	urethral	JJ	I-NP	O
meatus	meatus	NN	I-NP	O
open	open	JJ	I-NP	O
.5	.5	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
be	be	VB	B-VP	O
sure	sure	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
checked	check	VBN	B-VP	O
in	in	IN	B-PP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Please	Please	NN	I-NP	O
follow-up	follow-up	NN	I-NP	O
on	on	IN	B-PP	O
ECHO	ECHO	NN	B-NP	O
results	result	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Please	Please	NNP	I-NP	O
check	check	NN	I-NP	O
INR	INR	NNP	B-NP	O
2-3	2-3	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
because	because	IN	B-SBAR	O
Levofloxacin	Levofloxacin	NN	B-NP	O
can	can	MD	B-VP	O
increase	increase	VB	I-VP	O
INR	INR	NN	B-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
AITA	AITA	NN	B-NP	B-protein
,	,	,	O	O
ROCKY	ROCKY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TJ09	TJ09	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/18/05	10/18/05	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
07	07	CD	B-NP	O
AM	AM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

